Literature DB >> 15325256

Role of the membrane fusion protein in the assembly of resistance-nodulation-cell division multidrug efflux pump in Pseudomonas aeruginosa.

Vladislav V Mokhonov1, Ekaterina I Mokhonova, Hiroyuki Akama, Taiji Nakae.   

Abstract

The tripartite xenobiotic-antibiotic transporter of Pseudomonas aeruginosa consists of the inner membrane transporter (e.g., MexB, MexY), the periplasmic membrane-fusion-protein (e.g., MexA, MexX), and the outer membrane channel protein (e.g., OprM). These subunits were assumed to assemble into a transporter unit during export of the substrates. However, subunit interaction and their specificity in native form remained to be elucidated. To address these important questions, we analyzed the role of the individual subunits for the assembly of MexAB-OprM by pull-down assay tagging only one of the subunits. We found stable MexA-MexB-OprM complex without chemical cross-linking that withstand all purification procedures. Results of bi-partite interactions analysis showed tight association between MexA and OprM in the absence of MexB, whereas the expression systems lacking MexA failed to co-purify MexB or OprM. None of the heterologous subunit combinations such as MexA+MexY(his)+OprM and MexX+MexB(his)+OprM showed interaction. These results implied that the membrane fusion protein is central to the tripartite xenobiotic transporter assembly.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15325256     DOI: 10.1016/j.bbrc.2004.07.140

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

Review 1.  Vacuuming the periplasm.

Authors:  Olga Lomovskaya; Maxim Totrov
Journal:  J Bacteriol       Date:  2005-03       Impact factor: 3.490

2.  Interaction of the MexA and MexB components of the MexAB-OprM multidrug efflux system of Pseudomonas aeruginosa: identification of MexA extragenic suppressors of a T578I mutation in MexB.

Authors:  Dominic Nehme; Keith Poole
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

Review 3.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

4.  Structure, Assembly, and Function of Tripartite Efflux and Type 1 Secretion Systems in Gram-Negative Bacteria.

Authors:  Ilyas Alav; Jessica Kobylka; Miriam S Kuth; Klaas M Pos; Martin Picard; Jessica M A Blair; Vassiliy N Bavro
Journal:  Chem Rev       Date:  2021-04-28       Impact factor: 60.622

5.  Induction of the MexXY efflux pump in Pseudomonas aeruginosa is dependent on drug-ribosome interaction.

Authors:  Katy Jeannot; Mara L Sobel; Farid El Garch; Keith Poole; Patrick Plésiat
Journal:  J Bacteriol       Date:  2005-08       Impact factor: 3.490

Review 6.  Assembly and transport mechanism of tripartite drug efflux systems.

Authors:  Rajeev Misra; Vassiliy N Bavro
Journal:  Biochim Biophys Acta       Date:  2009-03-13

7.  Structural basis for the inhibition of bacterial multidrug exporters.

Authors:  Ryosuke Nakashima; Keisuke Sakurai; Seiji Yamasaki; Katsuhiko Hayashi; Chikahiro Nagata; Kazuki Hoshino; Yoshikuni Onodera; Kunihiko Nishino; Akihito Yamaguchi
Journal:  Nature       Date:  2013-06-30       Impact factor: 49.962

8.  Assembly of the MexAB-OprM multidrug pump of Pseudomonas aeruginosa: component interactions defined by the study of pump mutant suppressors.

Authors:  Dominic Nehme; Keith Poole
Journal:  J Bacteriol       Date:  2007-06-22       Impact factor: 3.490

9.  Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.

Authors:  Lucie Vettoretti; Patrick Plésiat; Cédric Muller; Farid El Garch; Gilles Phan; Inna Attrée; Arnaud Ducruix; Catherine Llanes
Journal:  Antimicrob Agents Chemother       Date:  2009-03-02       Impact factor: 5.191

10.  Evaluation of multidrug efflux pump inhibitors by a new method using microfluidic channels.

Authors:  Yoshimi Matsumoto; Kohei Hayama; Shouichi Sakakihara; Kunihiko Nishino; Hiroyuki Noji; Ryota Iino; Akihito Yamaguchi
Journal:  PLoS One       Date:  2011-04-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.